Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wedlund

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|August 16, 2003
Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizersJose de Leon, Lori Dinsmore, Peter Wedlund
Journal of the National Medical Association|October 24, 2008
Smoking risk and the likelihood of quitting among African-American female light and heavy smokersAnita Fernander, Mitzi Schumacher, Xiaochen Wei, et al.
Journal of Clinical Psychopharmacology|November 13, 2004
Haloperidol half-life after chronic dosingJose de Leon, Francisco J Diaz, Peter Wedlund, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|August 16, 2003
Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizersJose de Leon, Lori Dinsmore, Peter Wedlund
Journal of the National Medical Association|October 24, 2008
Smoking risk and the likelihood of quitting among African-American female light and heavy smokersAnita Fernander, Mitzi Schumacher, Xiaochen Wei, et al.
Journal of Clinical Psychopharmacology|November 13, 2004
Haloperidol half-life after chronic dosingJose de Leon, Francisco J Diaz, Peter Wedlund, et al.
Pageof 1